Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Efraim Idelevich"'
Autor:
Ashraf Imam, Daniel Gold, Guy Pines, Arie Pelta, Eli Mavor, Efraim Idelevich, Harbi Khalayleh
Publikováno v:
Journal of Coloproctology, Vol 39, Iss 1, Pp 67-69 (2019)
Herein we present a rare case of anal canal adenocarcinoma manifesting as non-healing perianal abscess that subsequently underwent radiochemotherapy followed by abdominoperineal resection for residual disease. The patient recovered, and a year later
Externí odkaz:
https://doaj.org/article/503e92ad181a4206a65921250577a32f
Autor:
Baruch Brenner, Michal Sarfaty, Ofer Purim, Yulia Kundel, Limor Amit, Amir Abramovich, Udi Sadeh Gonik, Efraim Idelevich, Noa Gordon, Gal Medalia, Aaron Sulkes
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0157548 (2016)
Current treatment options for advanced esophagogastric cancer (AEGC) are still unsatisfactory. The aim of this prospective phase Ib/II study was to evaluate the safety and efficacy of a novel regimen, AVDCX, consisting of weekly docetaxel and cisplat
Externí odkaz:
https://doaj.org/article/88de818c807e42978bce4763baaf7652
Autor:
Tammi Arbel Rubinstein, Efraim Idelevich, Gennady Kouniavsky, Li Or Lazar, Bibi Kanengisser Pines, Amir Elami, Guy Pines, Ilan Bar
Publikováno v:
The Annals of Thoracic Surgery. 108:e349-e351
Paragangliomas are rare neuroendocrine tumors derived from extraadrenal autonomic paraganglia, which may secrete catecholamines. They are potentially metastatic and require very long-term follow-up. Esophageal paragangliomas are extremely rare and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b60962ef9d81dc5e89ef2621404e3d4e
https://doi.org/10.1016/j.athoracsur.2019.03.106
https://doi.org/10.1016/j.athoracsur.2019.03.106
Autor:
Diana Matceyevsky, Moshe Inbar, Felix Bokstein, Baruch Brenner, Arie Figer, Tamar Peretz, Lior Soussan-Gutman, Addie Dvir, Ronen Brenner, Ayala Hubert, Amiel Segal, Elizabeth Dudnik, Alexander Beny, David Sarid, Andreas Voss, Ofer Purim, Katerina Shulman, Mark Temper, Sharon Pelles-Avraham, Efraim Idelevich, Amichay Meirovitz, Valeriya Semenisty, D. Limon, Kenneth J. Russell
Publikováno v:
Targeted Oncology
Background Precision treatment of cancer uses biomarker-driven therapy to individualize and optimize patient care. Objective To evaluate real-life clinical experience with biomarker-driven therapy in metastatic gastric and esophageal cancer in Israel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c72f7f0ae542aa81fbae21b9658b6ae
https://doi.org/10.1007/s11523-017-0548-8
https://doi.org/10.1007/s11523-017-0548-8
Autor:
Sophia Man, Irit Ben-Aharon, Mariana Steiner, Moshe Mishaeli, Katerina Shulman, Sara Morgenstern, Efraim Idelevich, Tal Goshen-Lago, Baruch Brenner, Michal Sternschuss, Lior Soussan-Gutman, Ayala Hubert, Nicky Liebermann, Alexander Beny, Ygael Dror, Ravit Geva
Background Anatomic location of primary tumors across the colon correlate with survival in the metastatic setting, whereas left-sided tumors may exhibit superior survival compared with right-sided tumors. The Oncotype Recurrence Score (RS) assay is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ba5db310110bff1dd935fb488fdc1ad
https://europepmc.org/articles/PMC6693694/
https://europepmc.org/articles/PMC6693694/
Autor:
Baruch Brenner, Eyal Fenig, Yulia Kundel, Aaron Sulkes, Tal Goshen-Lago, Efraim Idelevich, Ofer Purim, Nikolai Menasherov, Noa Gordon, Hanoch Kashtan
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 134
AIM This phase IB/II study evaluated the safety and efficacy of the addition of cetuximab to standard preoperative chemoradiotherapy (CRT) in locally advanced esophageal cancer (LAEC). METHODS Patients (pts) with resectable LAEC (T2-3N0-1M0, T1-3N1M0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d193ef88ea7c67ee0f7977865a1459
https://pubmed.ncbi.nlm.nih.gov/31005227
https://pubmed.ncbi.nlm.nih.gov/31005227
Autor:
Ravit Geva, Ayala Hubert, Alexander Gluzman, Baruch Brenner, Ygael Dror, Einat Shacham-Shmueli, Lior Soussan-Gutman, Moshe Mishaeli, Ofer Purim, Haluk Tezcan, Alexander Beny, Efraim Idelevich, Sophia Man, Nicky Liebermann, Calvin Chao, Mariana Steiner, Adi Shani, Katerina Shulman, Megan P. Rothney
Publikováno v:
Value in Health. 19(1):82-87
ObjectivesTo evaluate the impact of the 12-gene Colon Cancer Recurrence Score Assay—a clinically validated prognosticator in stage II colon cancer after surgical resection—on adjuvant treatment decisions in T3 mismatch repair proficient (MMR-P) s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef7850b1cb7d599d22b661fc78946a1
Autor:
Yulia Kundel, Yoram Klein, Baruch Brenner, Hanoch Kashtan, Efraim Idelevich, Michael Dinerman, Margarita Tokar, Noa Ben Baruch, Victor Buevich
Publikováno v:
Onkologie. 35:427-431
Background: We investigated the efficacy and tolerability of cisplatin and 5-fluorouracil (5-FU) plus bevacizumab as neoadjuvant therapy for patients with locally advanced resectable esophageal cancer. Patients and Methods: In this prospective phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ad125665496437a418b0366d06f70cf
https://doi.org/10.1159/000340072
https://doi.org/10.1159/000340072
Autor:
Efraim Idelevich, Baruch Brenner, Jaqueline Sulkes, Aaron Sulkes, Ofer Purim, Ayelet Dreznik, Yulia Kundel
Publikováno v:
Journal of Surgical Oncology. 105:316-322
Background Gastric cancer (GC) in Israel remains incompletely characterized. The aim of this study was to define the clinical and pathological characteristics of GC in Israel and to compare them to the general Western population. Patients and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6634190cbd7ef7cbd5ebc27f1090696d
https://doi.org/10.1002/jso.22078
https://doi.org/10.1002/jso.22078
Autor:
Adi Shani, Arie Ariche, Franklin Greif, Hanoch Kashtan, Efraim Idelevich, Eli Mavor, Michael Dinerman, Baruch Brenner, Rafael Miller, Sergo Susmalian, Noa Ben Baruch
Publikováno v:
Chemotherapy. 55:76-82
Background: Compared with systemic therapy, hepatic arterial infusion (HAI) increases the response to fluoropyrimidines. Methods: Thirty-one patients with non-resectable, colorectal cancer (CRC) liver metastases received irinotecan 120 mg/m2, followe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7818eb76275a1fa4af0c38c520d3909
https://doi.org/10.1159/000183732
https://doi.org/10.1159/000183732